Outset Medical plunges after suspension of guidance, shipment hold

Outset Medical

13/06/2022 23:21

** Shares of medical technology co Outset Medical  OM.O 
down 21.6% at $16.01 in extended trade 
    ** Co said it has implemented a shipment hold on the
distribution of its Tablo Hemodialysis System for home use
pending the FDA review and clearance of an application it
submitted  urn:newsml:reuters.com:*:nBw6WG56Ga
    ** OM also suspends its prior guidance; Says it will provide
an update on the outlook in early August 
    ** Five of six brokerages rate the stock "buy" or higher,
one "hold"; their median PT is $50 - Refinitiv
    ** As of last close, shares have shed over half their value
this year

 (Reporting by Manya Saini in Bengaluru)
 ((Manya.Saini@thomsonreuters.com;))